We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$632M
AUM Growth
-$113M
Cap. Flow
-$7.1M
Cap. Flow %
-1.12%
Top 10 Hldgs %
37.16%
Holding
136
New
4
Increased
38
Reduced
62
Closed
11

Top Buys

Rank Stock Value
1
GNRC icon
Generac Holdings
GNRC
+$4.67M
2
WSO icon
Watsco Inc
WSO
+$4.06M
3
IDXX icon
Idexx Laboratories
IDXX
+$3.7M
4
GS icon
Goldman Sachs
GS
+$3.43M
5
ZS icon
Zscaler
ZS
+$3.28M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$6.3M
2
NTNX icon
Nutanix
NTNX
+$5.81M
3
DIS icon
Walt Disney
DIS
+$4.75M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.57M
5
ABBV icon
AbbVie
ABBV
+$3.47M

Sector Composition

Rank Sector Weight
1 Healthcare 28.31%
2 Technology 23.98%
3 Industrials 11.07%
4 Consumer Staples 8.52%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$46.8M 7.41%
342,548
-2,526
-0.7% -$383K
VCSH icon
2
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$30.4M 4.81%
398,128
-32,757
-8% -$2.52M
MSFT icon
3
Microsoft
MSFT
$3.81T
$29M 4.6%
113,092
+4,403
+4% +$1.19M
JPM icon
4
JPMorgan Chase
JPM
$951B
$24.5M 3.87%
217,279
+25,079
+13% +$3.11M
JNJ icon
5
Johnson & Johnson
JNJ
$646B
$21.4M 3.39%
120,683
-1,043
-0.9% -$186K
SYK icon
6
Stryker
SYK
$127B
$18.4M 2.92%
92,617
+3,065
+3% +$720K
TMO icon
7
Thermo Fisher Scientific
TMO
$230B
$17.8M 2.82%
32,829
-699
-2% -$385K
ECL icon
8
Ecolab
ECL
$80.4B
$16M 2.53%
104,152
+13,715
+15% +$2.27M
ALC icon
9
Alcon
ALC
$34.8B
$15.2M 2.41%
218,074
+6,146
+3% +$448K
ABBV icon
10
AbbVie
ABBV
$451B
$15.2M 2.4%
99,024
-22,693
-19% -$3.47M
PAYX icon
11
Paychex
PAYX
$45.2B
$15M 2.37%
131,486
-5,941
-4% -$746K
RTX icon
12
RTX Corp
RTX
$285B
$14.9M 2.35%
154,619
+814
+0.5% +$78.3K
MRK icon
13
Merck
MRK
$366B
$13.9M 2.2%
152,493
-6,620
-4% -$587K
WSO icon
14
Watsco Inc
WSO
$12.8B
$13.7M 2.16%
57,260
+15,413
+37% +$4.06M
STE icon
15
Steris
STE
$22.8B
$12.1M 1.91%
58,529
-1,521
-3% -$343K
INTC icon
16
Intel
INTC
$473B
$11.7M 1.85%
312,691
+4,944
+2% +$214K
MRVL icon
17
Marvell Technology
MRVL
$195B
$11.3M 1.79%
259,986
+6,778
+3% +$384K
MDT icon
18
Medtronic
MDT
$117B
$11.1M 1.76%
123,790
+20,951
+20% +$2.12M
PEP icon
19
PepsiCo
PEP
$193B
$11.1M 1.75%
66,485
-1,328
-2% -$224K
KO icon
20
Coca-Cola
KO
$386B
$10.4M 1.65%
165,330
-2,863
-2% -$181K
HOLX
21
DELISTED
Hologic
HOLX
$10.1M 1.6%
145,741
-3,200
-2% -$238K
CAT icon
22
Caterpillar
CAT
$368B
$9.5M 1.5%
53,128
-2,127
-4% -$448K
BMY icon
23
Bristol-Myers Squibb
BMY
$136B
$9.41M 1.49%
122,238
-59,980
-33% -$4.57M
VMC icon
24
Vulcan Materials
VMC
$35.6B
$9.37M 1.48%
65,943
-2,413
-4% -$398K
GS icon
25
Goldman Sachs
GS
$301B
$9.27M 1.47%
31,212
+11,026
+55% +$3.43M

Similar funds

LaFleur & Godfrey's Q2 2022 Portfolio in Review

As of Q2 2022, LaFleur & Godfrey held 136 positions worth $632M, down 15% from $744M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

LaFleur & Godfrey's Q2 2022 filing shows 4 new, 38 increased, 62 reduced and 11 closed positions. Its largest new stake was Generac Holdings: 18,984 shares worth $4M. The largest sale was First Solar, an estimated $6.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

  • LaFleur & Godfrey's largest Q2 2022 buy was Generac Holdings: 18,984 shares worth $4M.
  • LaFleur & Godfrey added most to Watsco Inc in Q2 2022, an estimated $4.06M increase.
  • LaFleur & Godfrey's biggest Q2 2022 reduction was First Solar, cutting an estimated $6.3M.
  • LaFleur & Godfrey fully exited VMware, Inc in Q2 2022, selling an estimated $3.02M.
  • LaFleur & Godfrey's ten largest holdings make up 37% of its $632M portfolio in Q2 2022.
  • LaFleur & Godfrey opened 4 new positions and closed 11 in Q2 2022.
  • LaFleur & Godfrey's portfolio value fell 15% quarter-over-quarter to $632M.

Based on LaFleur & Godfrey's 13F filing for Q2 2022, filed 26 Jul 2022.